Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach

Idarubicin-based 7+3 induction with contemporary supportive care yields good safety and CR rates, including in midostaurin-treated FLT3-mutated patients. Survival outcomes for adverse-risk AML patients remain suboptimal.

Authors

Institutions

Publication Details

Journal
Internal Medicine Journal
Published
2025-03-07
DOI
https://doi.org/10.1111/imj.70010
Citations
1
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
1.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach

Michael Löw, Shaun Fleming, Amanda Tey, Ashwini Bennett et al.
1 citations
Internal Medicine Journal
Acute Myeloid Leukemia Research
1.77
article

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach

Michael Löw, Shaun Fleming, Amanda Tey, Ashwini Bennett, Paul Yeh, Aditya Tedjaseputra, Zane Kaplan, Chong Chyn Chua, Anastasios Nalpantidis, S. Brown, Gareth Peter Gregory, Jake Shortt, Pasquale L. Fedele, Shahla Vilcassim, Michael Gilbertson, Danielle H. Oh, Sanjeev Chunilal, Stephen Opat, George Grigoriadis, Donna Gairns
article en
1 citations

Abstract

Idarubicin-based 7+3 induction with contemporary supportive care yields good safety and CR rates, including in midostaurin-treated FLT3-mutated patients. Survival outcomes for adverse-risk AML patients remain suboptimal.

Internal Medicine JournalVol. 55(5)
King's College London (GB), Walter and Eliza Hall Institute of Medical Research (AU), Guy's and St Thomas' NHS Foundation Trust (GB), Northern Hospital (AU), Monash Health (AU), Alfred Health (AU), Monash University (AU)
Haematology Society of Australia and New Zealand, RCPA Foundation, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 18%
Acute Myeloid Leukemia Research
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.